$124.01
0.720.58%
Pre-Market: 4:13 AM EDT
Neurocrine Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Neurocrine Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $1.81 | $1.51 | 19.9 % |
Jun 2024 | 2024-08-01 | $1.63 | $1.03 | 58.3 % |
Mar 2024 | 2024-05-01 | $1.20 | $1.01 | 18.8 % |
Dec 2023 | 2024-02-07 | $1.54 | $1.15 | 33.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $590.20M | $547.07M | 7.88 % |
Mar 2024 | 2024-05-01 | $515.30M | $511.97M | 0.65 % |
Dec 2023 | 2024-02-07 | $515.20M | $518.13M | -0.57 % |
Sep 2023 | 2023-10-31 | $498.80M | $469.92M | 6.15 % |
Neurocrine Biosciences (NBIX) is scheduled to report earnings on February 5, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
The Actual EPS was $1.81, which beat the estimate of $1.51.
The Actual Revenue was $622.1M, which beat the estimate of $600.6M.
Browse earnings estimates, EPS, and revenue on all stocks.